Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

Nexavar image

Torisel fails in head-to-head study with Nexavar

May 16, 2012 Research and Development, Sales and Marketing Bayer, Nexavar, Pfizer, Torisel, inlyta, rcc

Pfizer’s kidney cancer drug Torisel has failed to best Bayer’s Nexavar in a head-to-head trial.  The Phase III study was …
News

Pharma funds drug discovery partnership

May 16, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Dundee, MRC, drug discovery, funding, partnerships, pharma

Half a dozen pharma firms are contributing £14.4 million to work by Dundee University and the Medical Research Council (MRC) on …
News
Erbitux image

Merck KGaA’s colon cancer drug fails trial

May 16, 2012 Research and Development, Sales and Marketing Erbitux, Merck KGaA, Merck Serono, colon cancer

Merck KGaA has suffered a setback with key brand Erbitux as the colerectal cancer drug failed in a late-stage trial.  …
News

Capturing the Brazilian pharma opportunity

May 16, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brazil, McKinsey, market access, middle class, pharma

 Many multinationals are hungry to sell their goods and services to the emerging markets’ growing middle class, comprising nearly two …
Feature

Merck KGaA sets out savings target as staff threaten to strike

May 15, 2012 Research and Development, Sales and Marketing Merck KGaA, R&D, Serono, cuts

Merck KGaA has outlined its plan to make €300 million in savings from its Serono drugs unit, with over half …
News

CoreLab Partners collaborates at industry conferences worldwide

May 15, 2012 Research and Development

Princeton, NJ May 15, 2012 – CoreLab Partners, Inc, a leading independent core lab providing centralized cardiac safety services and …
News
Press release
GSK picture

GlaxoSmithKline to acquire Cellzome for £61 million

May 15, 2012 Research and Development, Sales and Marketing Cellzome, Domantis, GSK, R&D

GlaxoSmithKline will expand its platform technology capability with the acquisition of a chemical proteomics company.  GSK will acquire those shares …
News

Synthetic Biologics appoints Carol Reed

May 15, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Carol Reed, Synthetic

Synthetic Biologics has appointed Carol Reed as senior vice president of Clinical & Regulatory Affairs. In this position Reed will …
Appointment

New Quad HIV pill on track for FDA approval

May 14, 2012 Research and Development, Sales and Marketing BMS, Compera, FDA, Gilead, HIV, The Quad

Gilead Sciences’ four-in-one HIV pill has been given the thumbs up by an FDA advisory group.  The US regulator is …
News
FDA picture

Obesity drugs vie for approval as FDA panel backs lorcaserin

May 14, 2012 Research and Development, Sales and Marketing Arena, Eisai, FDA, Qnexa, lorcaserin, obesity

An FDA panel has recommended Arena’s obesity drug lorcaserin, setting up a showdown with Vivus’ Qnexa. Qnexa was recommended by an FDA panel …
News

Gamification and online communities – what can pharma do?

May 10, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer, Facebook, Gamification, Syrum, digital marketing

Gamification is the new buzzword in digital marketing and has the potential to engage consumers more than traditional strategies. This new …
Feature
neil_weir_abpi-12

ABPI appoints new Innovation Board Chair

May 10, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Neil Weir, Whitehead

The senior vice president of discovery at UCB, Neil Weir, has been appointed as the next Chair of the ABPI …
Appointment
dr_jeremy_levin_web_only

Teva appoints new president and chief executive

May 10, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Jeremy Levin, Teva

Ex-BMS head Dr Jeremy Levin has been appointed president and chief executive of Teva.  Prior to joining Teva, Levin, who …
Appointment

Novo Nordisk appoints ex-Pfizer head

May 10, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, Pfizer, Robert Clark, regulatory affairs

Robert Clark will be joining Novo Nordisk as vice president, regulatory affairs. Clark will lead Novo Nordisk’s US regulatory team, …
Appointment

Teva appoints new president of R&D

May 9, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Michael Hayden, R&D, Teva

Teva has appointed Dr Michael Hayden as its new president of global R&D and chief scientific officer at the firm’s …
Appointment
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026